Bitcoin is just all over the place, isn’t it? [caption id="attachment_1779" align="aligncenter" width="300"] (Image Courtesy: Pixabay)[/caption] Over the past couple of months,
Categories
Other Industries
WHO’s Bloomberg is all set to smoke out the tobacco giants
While your favorite westerns might have popularised the glitzy image of smoking, the new age of anti-tobacco health movements has a fresh
Tips from the housing sector to feel at home!
Across the globe, it’s everyone’s dream to have a roof over their heads — which is also one of the most difficult
The two sides of the Eli Lilly coin
The performance of pharma and biotech stocks from 2017 to this year has been quiet impressive. Adding on, analysts expect pharma stocks
Steel tariffs: a cause of concern?
[caption id="attachment_1587" align="alignleft" width="300"] (Image Courtesy: David J. Fred, Wikimedia Commons)[/caption] President Donald Trump has imposed import tariffs of 25% on steel
Wynn Resorts – “Me Too”
A popular song from back in the ‘70s goes like this … “I’m woman, hear me roar, in numbers too big to
Vail Resorts, Inc. Q2 2018 earnings snapshot
Mountain resort company Vail Resorts reported positive top and bottom line results for the second quarter. Profit was driven by a one-time
Promising cryptocoins priced under $2
Is Bitcoin still a good investment after the fall this year? We have our concerns, the primary one being that the current
Is the struggle over for Mattel?
There was a time when Mattel was a household name. With brands like Barbie, Hot Wheels, and Fisher-Price, Mattel was once recognized
Is Johnson & Johnson a ‘sell’ in 2018?
Johnson & Johnson may not be having a great 2018 so far with the stock ticking down about 8% since the year
Dermira suffers a fatal fall after catastrophic trial fail
Investors are ruthless if companies fail to fulfill their promises – a fact that especially applies to pharma companies. And Dermira learned
P&G trimmed $200 million in digital ad costs last year
Procter & Gamble (PG), the world’s biggest marketer, last year raised a few eyebrows after it highlighted how broken and ineffective the
Dick’s Sporting Goods vows stringent curbs on firearm sale
Even as the need for proper legislation to control gun sales is vehemently debated on various forums, one more firm has joined
American Outdoor Brands Corp. Q3 2018 earnings snapshot
Firearms manufacturer American Outdoor Brands (AOBC) reported a plunge in top and bottom line results for the third quarter of 2018. The
Celgene’s potential blockbuster drug filing fails to pass the muster with the FDA
U.S. Food and Drug Administration (FDA) has sent a "Refuse to file" letter to Celgene with regards to the New Drug Application
New flu vaccine brings Novavax back to life
Novavax shares skyrocketed after the company’s latest study into its flu vaccine offered promising results. The company’s vaccine for flu, NanoFlu, generated
Dietary supplements market has great growth opportunities
Many investors stay away from pharma stocks as their research and products often tend to mirror rocket science. Also, growth is generally
Mylan N.V. Q4 2017 earnings snapshot
Generic and specialty pharmaceuticals company Mylan reported a 41.4% plunge in its fourth quarter earnings to $244.3 million, impacted by the recognition
Uber’s Frances Frei says adieu to full-time role
Frances Frei, who is the SVP of Leadership and Strategy at Uber, is departing from her full-time job at the company. She
Sempra Energy Q4 2017 earnings snapshot
Energy services holding company Sempra Energy reported a marginal spike in its revenue for fourth quarter 2017 of 3.2% to $2.96 billion
Valeant Pharmaceuticals International Inc. Q4 2017 earnings snapshot
Canada’s Valeant Pharmaceuticals posted a 9.9% decline in its fourth quarter 2017 revenue, driven by the impact of divestitures and lower volumes